Annual Total Long Term Liabilities
$1.05 M
-$713.00 K-40.33%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual total long term liabilities is $1.05 million, with the most recent change of -$713.00 thousand (-40.33%) on December 31, 2023.
- During the last 3 years, RGLS annual total long term liabilities has risen by +$1.05 million (+100.00%).
- RGLS annual total long term liabilities is now -98.52% below its all-time high of $71.53 million, reached on December 31, 2011.
Performance
RGLS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$476.00 K
-$199.00 K-29.48%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly total long term liabilities is $476.00 thousand, with the most recent change of -$199.00 thousand (-29.48%) on September 30, 2024.
- Over the past year, RGLS quarterly long term liabilities has dropped by -$199.00 thousand (-29.48%).
- RGLS quarterly long term liabilities is now -99.39% below its all-time high of $78.46 million, reached on September 30, 2012.
Performance
RGLS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RGLS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.3% | -29.5% |
| 3 y3 years | +100.0% | -92.2% |
| 5 y5 years | -85.2% | -13.3% |
RGLS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.2% | at low | -94.2% | at low |
| 5 y | 5-year | -87.2% | -100.0% | -94.2% | -100.0% |
| alltime | all time | -98.5% | -100.0% | -99.4% | -100.0% |
Regulus Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $476.00 K(-29.5%) |
| Jun 2024 | - | $675.00 K(-22.2%) |
| Mar 2024 | - | $868.00 K(-17.7%) |
| Dec 2023 | $1.05 M(-40.3%) | $1.05 M(-14.9%) |
| Sep 2023 | - | $1.24 M(-12.7%) |
| Jun 2023 | - | $1.42 M(-11.1%) |
| Mar 2023 | - | $1.60 M(-9.6%) |
| Dec 2022 | $1.77 M(-78.6%) | $1.77 M(-8.7%) |
| Sep 2022 | - | $1.94 M(-68.3%) |
| Jun 2022 | - | $6.10 M(-13.4%) |
| Mar 2022 | - | $7.04 M(-14.8%) |
| Dec 2021 | $8.27 M(>+9900.0%) | $8.27 M(+221.8%) |
| Sep 2021 | - | $2.57 M(-5.5%) |
| Jun 2021 | - | $2.72 M(-5.1%) |
| Mar 2021 | - | $2.87 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2020 | - | $110.00 K(-49.3%) |
| Jun 2020 | - | $217.00 K(-31.8%) |
| Mar 2020 | - | $318.00 K(-32.1%) |
| Dec 2019 | $468.00 K(-93.4%) | $468.00 K(-14.8%) |
| Sep 2019 | - | $549.00 K(+19.1%) |
| Jun 2019 | - | $461.00 K(-58.3%) |
| Mar 2019 | - | $1.11 M(-84.5%) |
| Dec 2018 | $7.13 M | $7.13 M(-5.3%) |
| Sep 2018 | - | $7.54 M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $7.94 M(-4.0%) |
| Mar 2018 | - | $8.27 M(-17.2%) |
| Dec 2017 | $9.99 M(-67.5%) | $9.99 M(-67.2%) |
| Sep 2017 | - | $30.51 M(-0.8%) |
| Jun 2017 | - | $30.74 M(-0.4%) |
| Mar 2017 | - | $30.87 M(+0.3%) |
| Dec 2016 | $30.78 M(+603.8%) | $30.78 M(+1.2%) |
| Sep 2016 | - | $30.43 M(+0.1%) |
| Jun 2016 | - | $30.39 M(+207.0%) |
| Mar 2016 | - | $9.90 M(+126.3%) |
| Dec 2015 | $4.37 M(+2.3%) | $4.37 M(+57.5%) |
| Sep 2015 | - | $2.78 M(-10.2%) |
| Jun 2015 | - | $3.09 M(-15.8%) |
| Mar 2015 | - | $3.67 M(-14.1%) |
| Dec 2014 | $4.27 M(-77.8%) | $4.27 M(-76.3%) |
| Sep 2014 | - | $18.04 M(-12.3%) |
| Jun 2014 | - | $20.57 M(-7.6%) |
| Mar 2014 | - | $22.25 M(+15.7%) |
| Dec 2013 | $19.24 M(-32.9%) | $19.24 M(-14.9%) |
| Sep 2013 | - | $22.62 M(-6.5%) |
| Jun 2013 | - | $24.19 M(-15.0%) |
| Mar 2013 | - | $28.47 M(-0.7%) |
| Dec 2012 | $28.66 M(-59.9%) | $28.66 M(-63.5%) |
| Sep 2012 | - | $78.46 M(+464.2%) |
| Jun 2012 | - | $13.91 M(-80.6%) |
| Dec 2011 | $71.53 M | $71.53 M |
FAQ
- What is Regulus Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics annual total long term liabilities year-on-year change?
- What is Regulus Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly long term liabilities year-on-year change?
What is Regulus Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RGLS is $1.05 M
What is the all time high annual total long term liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high annual total long term liabilities is $71.53 M
What is Regulus Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RGLS annual total long term liabilities has changed by -$713.00 K (-40.33%)
What is Regulus Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RGLS is $476.00 K
What is the all time high quarterly long term liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly total long term liabilities is $78.46 M
What is Regulus Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RGLS quarterly total long term liabilities has changed by -$199.00 K (-29.48%)